
GALAXY
@livergalaxy
Gut-and-liver axis in alcoholic liver fibrosis. Exploring the role of the gut microbiome in alcoholic liver fibrosis. Receives funding from @EU_H2020.
ID: 776863261409046529
http://livergalaxy.eu 16-09-2016 19:20:10
357 Tweet
551 Followers
144 Following

Remember to apply for EASLnews AASLD MASTERCLASS in Georgia US - top interactive forum for next generation leaders in hepatology from Europe and US. W Ray Kim Debbie Shawcross Eric Trépo Sven Francque Jasmohan Bajaj



2023 journal impact factors are out- check out Liver and GI Super proud of EASLnews journals KUDOS to the teams, AE’s, office, reviewers and authors🙏 EASL Crown Jewels in good shape❤️ Journal of Hepatology JHEP Reports Paolo Angeli #JosepLlovet


💥Review Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases Read it here👉journal-of-hepatology.eu/article/S0168-… Maja Thiele ida villesen Aleksander Krag GALAXY #LiverTwitter





All you need to know about Steatotic Liver Disease! The Lancet Seminar on SLD👇 A clinician-centered guide covering all from epidemiology, nomenclature, natural history, diagnosis and treatment to healthcare pathways. thelancet.com/journals/lance… #ManolisTsochatzis Sven Francque


Ever heard about the “Steatotic Liver Disease burden paradox”? Check it out 👇👇👇 Perspective in Nature Reviews Gastroenterology & Hepatology rdcu.be/d2wcV



Meet LiverPro - a novel digital automated tool to assess risk of fibrosis in the population and primary care ⁃First CE approved tool👉ready for clinical use ⁃Let’s improve care pathways in SLD 🤩@KatrinePLindvig Today in The Lancet Gastroenterology & Hepatology sciencedirect.com/science/articl…





🍺❌On 11 December 2024, EASL, represented by Aleksander Krag Shira zelber sagi, and Frank Murray, partnered with WHO/Europe to launch the European Alcohol Health Alliance Symposium in Copenhagen. During the symposium, representatives from 21 pan-European medical societies and health


Excellent review on steatotic liver disease. #MASLD #MASH Aleksander Krag pubmed.ncbi.nlm.nih.gov/39488409/


Impact of under reporting of alcohol consumption in persons with Steatotic Liver Disease? What is the true distribution of MASLD vs MetALD/ALD in the population ? 😳10-57% underreporting! 👉 currently 10:1 -wrong! 👉 1:1 more likely ? The Lancet Gastroenterology & Hepatology Link 🔗👇



